Edifice Health is a spin-out company from a 10-year research study on immune profiling from Stanford University, the Stanford 1,000 Immunomes Project. The technology is the first biomarker composite scoring system to measure immune health and the Inflammatory Age of an individual which predicts the onset of multiple chronic diseases and provides comprehensive health insights designed to help people change the course of their aging process. Founded by David Furman and Mark Davis in 2018, Edifice Health is headquartered in San Mateo.